Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the-Reference-Cited by-同舟云学术

Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the

Published:2016-06-16 Issue:19 Volume:122 Page:2941-2951
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Giebel Sebastian¹,Czyz Anna²,Ottmann Oliver³,Baron Frederic⁴,Brissot Eolia⁵,Ciceri Fabio⁶,Cornelissen Jan J.⁷,Esteve Jordi⁸,Gorin Norbert-Claude⁵,Savani Bipin⁹,Schmid Christoph¹⁰,Mohty Mohamad⁵,Nagler Arnon¹¹¹²

Affiliation:

1. Department of Bone Marrow Transplantation and Onco-Hematology; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology; Gliwice Poland

2. Department of Hematology and Bone Marrow Transplantation; Poznan University of Medical Sciences; Poznan Poland

3. Institute of Cancer and Genetics; Cardiff University School of Medicine; Cardiff United Kingdom

4. Department of Hematology, Centre Hospitalier Universitaire Sart-Tilman; University of Liege; Belgium France

5. Clinical Hematology and Cellular Therapy Department, Hospital Saint-Antoine; Assistance Publique-Hôpitaux de Paris; Paris France

6. Hematology and Bone Marrow Transplantation (BMT) Unit; San Raffaele Scientific Institute; Milan Italy

7. Department of Hematology, Erasmus MC Cancer Institute; University Medical Center; Rotterdam the Netherlands

8. Hematology Department, August Pi i Sunyer Institute for Biomedical Research; Hospital Clinic; Barcelona Spain

9. Department of Hematology and Transplantation; Vanderbilt University; Nashville Tennessee

10. Department of Hematology and Oncology, Klinikum Augsburg; Ludwig-Maximilians-Universitaet; Munich Augsburg Germany

11. Division of Hematology and Bone Marrow Transplantation; Chaim Sheba Medical Center; Tel-Hashomer Israel

12. European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Office; Hospital Saint-Antoine; Paris France

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference54 articles.

1. Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Third International Workshop on Chromosomes in Leukemia;Bloomfield;Cancer Res.,1983

2. Patients' age and BCR-ABL frequency in adult B-precursor ALL: a retrospective analysis from the GMALL study group;Burmeister;Blood.,2008

3. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial;Moorman;Blood.,2007

4. Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia-results of the prospective multicenter LALA-94 trial;Dombret;Blood.,2002

5. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL-positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG);Wrzesien-Kus;Ann Hematol.,2006

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine Kinase Inhibitor-associated Cerebral Arterial Occlusive Disease Treated with High-flow Bypass Surgery: A Case Report;NMC Case Report Journal;2023-12-31

2. Global burden of leukemia attributable to occupational exposure to formaldehyde from 1990 to 2019;Environmental Science and Pollution Research;2023-12-12

3. Ponatinib Improved the Prognosis of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Japanese Single-Center Cohort Study;Cureus;2023-12-12

4. How to Manage Philadelphia-Positive Acute Lymphoblastic Leukemia in Resource-Constrained Settings;Cancers;2023-12-10

5. SOHO State of the Art Updates and Next Questions: Update on the Approach to Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia;Clinical Lymphoma Myeloma and Leukemia;2023-12